Peptilogics
Precision-engineered peptides to cure medical device infections
- Headquarters
- Pittsburgh, Pennsylvania
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- peptilogics.com
- Total Funding
- $113.4M
- Last Round
- $78.0M Series BOct 2025
About
Peptilogics is a clinical-stage biotechnology company that uses a human-AI peptide engineering platform to design novel peptide therapeutics. Its lead program, PLG0206, is in a pivotal Phase 2/3 trial for prosthetic joint infections (PJI) — the first potential approved therapy for the condition — and holds FDA Orphan Disease Designation, Fast Track, and QIDP status.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account